ABSENCE OF POINT MUTATIONS IN THE EXTRACELLULAR DOMAIN OF THE A SUBUNIT OF THE GM-CSF RECEPTOR IN A SERIES OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)

被引:0
|
作者
DECKER, J [1 ]
FIEDLER, W [1 ]
SAMALECOS, A [1 ]
HOSSFELD, DK [1 ]
机构
[1] UNIV HAMBURG,HOSP EPPENDORF,DEPT HEMATOL ONCOL,D-20246 HAMBURG,GERMANY
关键词
ACUTE MYELOID LEUKEMIA; GM-CSF RECEPTOR; POINT MUTATIONS; SEQUENCING;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The GM-CSF receptor belongs to the cytokine receptor superfamily. The high-affinity receptors of this class are lacking intrinsic tyrosine kinase domains. The GM-CSF receptor consists of alpha and beta subunits. The beta subunit is shared with the receptors of IL-3 and IL-5. In addition to the membrane bound forms the receptors have been found to possess soluble isoforms. Since retroviral infection of the human GM-CSF dependent cell line, TF-1, leads to factor independent growth by increased expression of the GM-CSF receptor alpha chain in a subgroup of infected clones, we were interested in studying the role of this chain in human AML. Further considering that a point mutation in the extracellular domain of the erythropoietin receptor, also a member of the cytokine receptor superfamily, resulted in constitutive activation of a murine cell line, we investigated the possibility that a point mutation of the GM-CSF receptor was responsible for autonomous growth of AML cells. We sequenced a segment of the receptor coding for the extracellular domain of the alpha subunit. cDNA was prepared from peripheral blood or bone marrow cells from 24 patients with AML, from four patients with MDS and from three human myeloid cell lines. The region of interest was amplified with two rounds of PCR reactions with nested primers, covering five overlapping fragments, and directly sequenced using a non-radioactive technique. No point mutations were found in the investigated samples. Thus, point mutations in this segment of the GM-CSF receptor gene do not seem to play an important role in the transformation process of human acute leukemia.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 50 条
  • [31] EXPRESSION OF IL-3 AND GM-CSF IN ACUTE MYELOID-LEUKEMIA BLAST CELLS DETECTED BY RT-PCR
    HASKOVEC, C
    GABERT, J
    LOPEZ, M
    MANNONI, P
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1101 - 1101
  • [33] Granulocyte-macrophage colony-stimulating factor (GM-CSF) multiple course priming in acute myeloid leukemia (AML).
    Buchner, T
    Hiddemann, W
    Wormann, B
    Zuhlsdorf, M
    Aswald, J
    Aswald, S
    Rottmann, R
    Maschmeier, G
    Ludwig, WD
    Sauerland, MC
    Heinecke, A
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 564 - 564
  • [34] Phase I trial of a novel diphtheria toxin/GM-CSF fusion protein in refractory or relapsed acute myeloid leukemia (AML).
    Frankel, AE
    Powell, BL
    Hall, PD
    Mone, AP
    Molnar, I
    Kreitman, RJ
    BLOOD, 2001, 98 (11) : 722A - 722A
  • [35] POINT MUTATIONS IN THE G-CSF-R GENE IN SEVERE CONGENITAL NEUTROPENIA TERMINATING IN ACUTE MYELOID-LEUKEMIA
    TOUW, IP
    SCHELEN, A
    BRYNES, RK
    TIDOW, N
    WELTE, K
    LOWENBERG, B
    DONG, F
    BLOOD, 1994, 84 (10) : A375 - A375
  • [36] IMPROVED PROGNOSIS IN MICE WITH ADVANCED MYELOID-LEUKEMIA FOLLOWING ADMINISTRATION OF GM-CSF AND CYTOSINE-ARABINOSIDE
    BENISHAY, Z
    PRINDULL, G
    SHARON, S
    LEUKEMIA RESEARCH, 1991, 15 (05) : 321 - 325
  • [37] Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF
    G Jahns-Streubel
    J Braess
    C Schoch
    C Fonatsch
    D Haase
    C Binder
    B Wörmann
    T Büchner
    W Hiddemann
    Leukemia, 2001, 15 : 377 - 384
  • [38] Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF
    Jahns-Streubel, G
    Braess, J
    Schoch, C
    Fonatsch, C
    Haase, D
    Binder, C
    Wörmann, B
    Büchner, T
    Hiddemann, W
    LEUKEMIA, 2001, 15 (03) : 377 - 384
  • [39] High-affinity binding to the GM-CSF receptor requires intact N-glycosylation sites in the extracellular domain of the β subunit
    Niu, LH
    Heaney, ML
    Vera, JC
    Golde, DW
    BLOOD, 2000, 95 (11) : 3357 - 3362
  • [40] GM-CSF during as well as after induction chemotherapy (CT) in elderly patients with acute myeloid leukemia (AML). The EORTC-HOVON phase III trial (AML 11).
    Lowenberg, B
    Suciu, S
    Zittoun, R
    Ossenkoppele, G
    Boogaerts, MA
    Wijermans, P
    Vellenga, E
    Berneman, Z
    Deffer, AW
    Sonneveld, P
    Stryckmans, P
    Solbu, G
    Dardenne, M
    deWitte, T
    Archimbaud, E
    BLOOD, 1995, 86 (10) : 1719 - 1719